Efficacy and safety of vunakizumab in moderate-to-severe chronic plaque psoriasis: A randomized, double-blind, placebo-controlled phase 3 trialKexiang Yan, Jinhua Xu, Ling Han et al.|Journal of the American Academy of Dermatology|2024Cited by 28
Efficacy and safety of pumecitinib 3% gel in treating mild-to-moderate atopic dermatitis: a multicentre randomized double-blind parallel placebo-controlled phase IIb clinical trialZhang Li, Mingyue Wang, Litao Zhang et al.|British Journal of Dermatology|2025Cited by 0